Vialwirebiotech, curated
October 2, 2026, 10:38 AM
June 19, 2026
- 9:00 AM · BioWorld9:00 AMConstantiam and Cincinnati Children’s enter Gaucher collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMScribe’s cardiometabolic programs gain CIRM boost — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMPrime Medicine’s PM-577a cleared for clinic for Wilson’s disease — BioWorld
- 9:00 AM · BioWorld9:00 AMEllison Medical Institute signs license agreement for QED-203 — BioWorld
- 9:00 AM · BioWorld9:00 AMMemento Medicines launches with focus on ophthalmology — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMBroken String Biosciences appoints Bruce Eaton to board — Drug Discovery World
- 6:00 AM · Drug Discovery World6:00 AMCERo reports positive data from AML Phase I trial — Drug Discovery World
- 5:22 AM · Pharmaceutical Technology5:22 AMVoro and Alloy partner on tumour-selective TCE therapeutics — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMResolution extends pipeline with in vivo RMT — Drug Discovery World
- 4:48 AM · Pharmaceutical Technology4:48 AMBiogen to acquire RayThera for up to $1bn — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMOvarian cancer vaccine with 40% survival rate to be advanced — Drug Discovery World
June 18, 2026
- 4:25 PM · BioPharma Dive4:25 PMModerna flu vaccine wins unanimous support from FDA panel — BioPharma Dive
- 3:56 PM · STAT News
- 12:00 PM · BioWorld12:00 PMGSK-Spero’s oral antibiotic Utebzi for cUTI wins US FDA nod — BioWorld
- 12:00 PM · BioWorld12:00 PMBiopharma IPOs stay strong as Kardigan prices upsized $400M offering — BioWorld
- 12:00 PM · BioWorld12:00 PMF2G preps NDA for first new antifungal in 20 years on solid phase III — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMcAMPfield lands $180M to build gut disease drug — BioPharma Dive